A research collaboration led by UCLA has announced a significant advancement in the measurement of how small molecules, including various drugs, bind to proteins.
This new technology is designed to complement an existing laboratory method known as pho, potentially providing researchers with enhanced tools for studying drug interactions.
Understanding these binding processes could be crucial for drug development, as it may help identify off-target effects that can complicate treatment outcomes.